logo
welcome
Reuters

Reuters

GlaxoSmithKline sues Moderna for US patent infringement over COVID vaccines

Reuters
Summary
Nutrition label

77% Informative

GlaxoSmithKline accuses Moderna of violating GSK 's patent rights in messenger RNA (mRNA) technology with its vaccine Spikevax .

GSK filed a related lawsuit against Pfizer and BioNTech in the same court in April over their COVID-19 vaccine.

Moderna earned $6.7 billion in revenue last year from SpikeVax .

A GSK spokesperson said the drugmaker is "willing to license these patents on commercially reasonable terms".

VR Score

87

Informative language

96

Neutral language

9

Article tone

formal

Language

English

Language complexity

62

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links